These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25919009)

  • 1. NGAL and ST2 levels in ambulatory patients with chronic heart failure. Clinical and echocardiographic correlates.
    Ventoulis I; Mantziari L; Mouratoglou SA; Kamperidis V; Giannakoulas G; Ziakas A; Tsalikakis D; Giamouzis G; Hitoglou-Makedou A; Karvounis H
    Scand Cardiovasc J; 2015 Aug; 49(4):213-9. PubMed ID: 25919009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B; Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Dobrzycki S
    Kidney Blood Press Res; 2009; 32(2):77-80. PubMed ID: 19287180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
    Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
    Nymo SH; Ueland T; Askevold ET; Flo TH; Kjekshus J; Hulthe J; Wikstrand J; McMurray J; Van Veldhuisen DJ; Gullestad L; Aukrust P; Yndestad A
    J Intern Med; 2012 May; 271(5):436-43. PubMed ID: 22211640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M; Lourenço P; Dias C; Amorim M; Rema J; Leite AB; Guimarães JT; Almeida P; Bettencourt P
    Int J Cardiol; 2013 Apr; 165(1):51-5. PubMed ID: 21872946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Gelatinase-Associated Lipocalin and depression in patients with chronic heart failure.
    Naudé PJ; Mommersteeg PM; Zijlstra WP; Gouweleeuw L; Kupper N; Eisel UL; Kop WJ; Schoemaker RG
    Brain Behav Immun; 2014 May; 38():59-65. PubMed ID: 24407045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
    Pronschinske KB; Qiu S; Wu C; Kato TS; Khawaja T; Takayama H; Naka Y; Templeton DL; George I; Farr MA; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2014 Dec; 33(12):1215-22. PubMed ID: 25049066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
    Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.
    Kirbiš S; Gorenjak M; Sinkovič A
    BMC Cardiovasc Disord; 2015 Jun; 15():49. PubMed ID: 26070595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
    Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
    Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
    Aghel A; Shrestha K; Mullens W; Borowski A; Tang WH
    J Card Fail; 2010 Jan; 16(1):49-54. PubMed ID: 20123318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of neutrophil gelatinase-associated lipocalin in children with heart failure.
    Tawfeek MS; Raafat DM; Saad K; Idriss NK; Sayed S; Fouad DA; El-Houfey AA
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):30-6. PubMed ID: 26627265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure.
    Shrestha K; Borowski AG; Troughton RW; Thomas JD; Klein AL; Tang WH
    J Card Fail; 2011 Jun; 17(6):472-8. PubMed ID: 21624735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure.
    Ojji DB; Lecour S; Adeyemi OM; Sliwa K
    Vasc Health Risk Manag; 2017; 13():311-316. PubMed ID: 28860791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure.
    Bolignano D; Basile G; Parisi P; Coppolino G; Nicocia G; Buemi M
    Rejuvenation Res; 2009 Feb; 12(1):7-14. PubMed ID: 19196011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME; Braam B; Diepenbroek A; van der Putten K; Cramer MJ; Wielders JP; Swinkels DW; Doevendans PA; Gaillard CA
    Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.